疏肝消瘿方联合西药治疗甲状腺功能亢进症的疗效
CSTR:
作者:
作者单位:

(台山市中医院,广东 台山 529200)

作者简介:

邓娉娉,女,主治医师,主要从事内分泌中西医结合诊疗工作。

通讯作者:

中图分类号:

R 581.1

基金项目:


Effect of Shugan Xiaoying Recipe Combined with Western Medicine on Hyperthyroidism
Author:
Affiliation:

(Taishan Hospital of Traditional Chinese Medicine, Guangdong Taishan 529200)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:观察疏肝消瘿方联合西药治疗甲状腺功能亢进症的疗效。方法:选取台山市中医院 2019 年 1 月至 2019 年 12 月收治的甲状腺功能亢进症患者 125 例作为研究对象,根据患者入院接受治疗的顺序分为对照组和观察组。对照组 59 例, 给予常规西药治疗;观察组 66 例,以疏肝消瘿方联合西药治疗。并对患者进行 6 个月的有效随访。比较两组患者治疗前后 的甲状腺功能水平,治疗疗效及不良反应发生率与复发率。结果:治疗前两组患者各项甲状腺水平比较,差异无统计学意义 (P > 0.05);治疗后,观察组患者游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)水平明显低于对照组,而促甲状 腺激素(TSH)水平明显高于对照组,差异具有统计学意义(P < 0.05)。观察组患者治疗后总有效率为 92.42 %,高于对 照组的 76.27 %,观察组患者复发率为 1.52 %,低于对照组的 10.17 %,不良反应发生率为 6.06 %,低于对照组的 33.90 %, 差异均具有统计学意义(P < 0.05)。结论:在甲状腺功能亢进症患者的治疗中,采取疏肝消瘿方联合西药治疗,可明显 的改善患者的甲状腺功能水平,提升临床治疗的疗效,降低治疗过程中发生的不良反应,效果理想。

    Abstract:

    〔Abstract〕 Objective To observe the effect of Shugan Xiaoying formula combined with western medicine on hyperthyroidism. Methods 125 patients with hyperthyroidism treated in Taishan Hospital of traditional Chinese medicine from January 2019 to December 2019 were selected as the research object. According to the order of admission, the patients were divided into control group and observation group. 59 cases in the control group were treated with conventional western medicine, and 66 cases in the observation group were treated with Shugan Xiaoying formula combined with western medicine. The patients were followed up for 6 months. The thyroid function level, therapeutic effect, incidence of adverse reactions and recurrence rate were compared between the two groups before and after treatment. Results There was no significant difference in thyroid levels between the two groups before treatment (P > 0.05); After treatment, the levels of FT3 and FT4 in the observation group were significantly lower than those in the control group, while the level of TSH was significantly higher than that in the control group (P < 0.05). The total effective rate of the observation group was 92.42%, higher than 76.27% of the control group, the recurrence rate of the observation group was 1.52%, lower than 10.17% of the control group, and the incidence of adverse reactions was 6.06%, lower than 33.90% of the control group (P < 0.05). Conclusion In the treatment of patients with hyperthyroidism, Shugan Xiaoying formula combined with western medicine can significantly improve the level of thyroid function, improve the curative effect of clinical treatment, and reduce the adverse reactions in the process of treatment.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-06-23
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-11-10
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭